Ypsomed Holding AG (CHIX:YPSNZ) Interest Received

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

CHIX:YPSNZ Ypsomed Holding AG CHIX:YPSNZ
79 GF Score
Price CHF408.20
GF Value CHF393.50
Valuation Fairly Valued
! 6 Warning Signs
View Full Analysis

What is Ypsomed Holding AG Interest Received?

Interest Received only applicable to companies reporting Cash Flow from Operations in direct method.

CHIX:YPSNZ
79GF Score
Ypsomed Holding AG CHIX:YPSNZ
Interest Received is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Ypsomed Holding AG (CHIX:YPSNZ) Overvalued in 2026?

Based on GuruFocus' analysis, Ypsomed Holding AG stock appears to be overvalued. The current stock price of CHF408.20 is trading 3.7% above its estimated GF Value™ of CHF393.50. GuruFocus considers Ypsomed Holding AG to be Fairly Valued.

Key valuation signals for CHIX:YPSNZ:

  • Interest Received:
  • GF Value™: CHF393.50 vs. price of CHF408.20 (3.7% above fair value)
  • GF Score™: 79/100 with 6 warning signs

No single metric tells the full story. See the CHIX:YPSNZ stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Ypsomed Holding AG Business Description

Address Brunnmattstrasse 6, Burgdorf, CHE, 3401
Ypsomed Holding AG is a Swiss company that develops and manufactures injection and infusion systems that allow patients to self-administer medication. Specifically, the company focuses on ensuring the ease of diabetes and insulin injection. The company offers various products such as pen needles with a click-on function. The company operates under two reportable segments: Ypsomed Delivery Systems and Ypsomed Diabetes Care.
79GF Score

Get the complete analysis for CHIX:YPSNZ

Interest Received is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

CHF408.20
Price
CHF393.50
GF Value